$47.18 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About PPD

PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services offerings span the lifecycle of clinical product development and includes product development and consulting services, early development services, phases II-IV clinical trial management, accelerated enrollment solutions, peri- and post-approval services and medical communications. The Company’s Laboratory Services segment offers bioanalytical laboratory services, biomarker laboratory services, vaccine science services, good manufacturing practice (GMP) laboratory services and central laboratory services.

Stock Analysis

last close $47.1
1-mo return -0.1%
3-mo return 1.7%
avg daily vol. 1.34M
52-week high 47.41
52-week low 31.54
market cap. $16.6B
forward pe 27
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $5.9B
inst own. 79.5%

Subscribe now for daily local and international financial news